HK2 and neoplasm: As shown in Figure 6A,B, under 5‐FU treatment, the tumour volume of the mice in the SPARC overexpression group was significantly larger than that in the control group, and this phenomenon was inhibited by the HK2 inhibitor 2‐DG.